NeuroSense Therapeutics FY EPS $(0.44) Misses $(0.35) Estimate
Benzinga Newsdesk 7 months ago
EarningsEarnings MissesNews
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
NeuroSense Therapeutics (NASDAQ:NRSN) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.35) by 25.71 percent.
NeuroSense Therapeutics (NASDAQ:NRSN) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.35) by 25.71 percent.
